Healthy Purpose logo

Learn about our commitment to the responsible use of antibiotics.

Or Filter by:

General Inquiries

Elanco Animal Health
2500 Innovation Way
Greenfield, IN 46140 USA



Media Contacts

Contact us.

Our Global Offices

Follow Elanco


Taking Action: Global Animal Protein Leaders, Public and Private Organizations Outline Future Path for Combatting Antimicrobial Resistance

Post by: Keri McGrath

WASHINGTON, D.C. (Sept. 22, 2016) -- More than 250 global food and health leaders representing the public and private sector gathered in Washington, D.C. this week at the One Health Summit, and declared priorities to help combat antimicrobial resistance as part of efforts to produce a sustainable food supply. 

The One Health Summit explored the following three core areas and created outcomes to help animal agriculture deliver on their commitments to help combat antimicrobial resistance:

  1. Increasing veterinary oversight: Veterinarians play a critical role in maintaining animal health and making the appropriate treatment decisions. Further, veterinarians are a critical link in preventing disease and antimicrobial resistance spread. However, there is a significant gap in veterinary availability and training in some countries, and even in parts of the United States.

Outcome: Summit participants formed a working group to establish a pilot project to develop and test a model for increasing veterinary capacity and training. The World Veterinary Association (WVA) has agreed to chair the working group. The American Association of Veterinary Medical Colleges (AAVMC) has offered to convene stakeholders to explore funding opportunities and build capacity. Finally, the Gates Foundation stated they will work with stakeholders to build connections and consider funding support in countries aligned with the Foundation’s strategy.

  1. Improving antimicrobial resistance monitoring and reporting: The lack of effective global measures and transparent reporting processes hinder the ability to track responsible antibiotic use, determine where progress against antimicrobial resistance is occurring, and where improvements are needed.

Outcome: The Summit participants agreed to continue working together to develop a process to collect and harmonize data on global antibiotic use and resistance across all livestock sectors.

  1. Accelerating innovation: Innovation is a critical pathway to address the challenge of antimicrobial resistance. Summit participants recognized there are significant barriers across regulatory, legislative and marketplace segments.

Outcome: A cross-functional working group formed to advance innovation and build public confidence in innovative solutions.

Tackling the challenge of antimicrobial resistance is bigger than one company or industry, requiring cross-sector stakeholders to come together. The One Health Summit is only the beginning – a catalyst for new actions and ideas to create a path forward.

About Elanco

Elanco provides comprehensive products and knowledge services to improve animal health and food-animal production in more than 70 countries around the world. We value innovation, both in scientific research and daily operations, and strive to cultivate a collaborative work environment for more than 6,500 employees worldwide. Together with our customers, we are committed to raising awareness about global food security, and celebrating and supporting the human-animal bond. Founded in 1954, Elanco is a division of Eli Lilly and Company. Our worldwide headquarters and research facilities are located in Greenfield, Indiana. Visit us at and


Media Statement from the participants of the One Health Summit September 21-22 in Washington, D.C., related to the United Nations’ General Assembly call to action on global antimicrobial resistance.

As members of the global animal protein community, we support the United Nations efforts to combat antimicrobial resistance as part of our efforts to produce a safe, sustainable food supply. We’ll each do our part to help maintain antibiotics’ long-term effectiveness to ensure the health of people, animals and the planet. We have identified the following priorities for the industry to focus on:

  1. Developing global standards of responsible antibiotic use in livestock.
  2. Support elimination of the use of shared-class antibiotics for growth promotion purposes globally, regardless of whether they are allowed by local regulations.
  3. Continue to identify new and better ways to care for animals to enhance animal welfare and reduce the need for antibiotics, including fostering an environment that stimulates innovation.
  4. Support increasing veterinary training and capacity, particularly in developing countries, to ensure proper use of antibiotics and other tools.
  5. Improving antimicrobial resistance monitoring and reporting, so we can accurately identify issues and track progress against resistance.

We recognize the importance of healthy animals and their impact on human health and the health of the environment, as well as their role in meeting the expected 60 percent increase in protein demand. Healthy animals mitigate antimicrobial resistance potential and reduce disease spread. Healthy animals have a better quality of life and fulfill the growing need for meat, milk and eggs to nourish the increasing global population. Healthy animals use resources more efficiently, lessening our environmental footprint.


We will work across the global protein food chain and the health systems to address this critical societal need, using a balanced, One Health approach to protect the health of animals, people and the planet.



Amick Farms




Cargill, Inc.

Cattle Empire, LLC

Christensen Farms

Cobb-Vantress, Inc.


Contegral, S.A.


Country Bird Holdings, Ltd.

Deseret Ranches of Florida

Elanco Animal Health


Friona Industries


Grupo Alimentario Guissona

Grupo Jorge


Land O’Lakes

Piensos Costa, S.A.

Pillen Family Farms



Sanderson Farms

Seaboard Foods


Simmons Foods

Smithfield Foods


Tyson Foods


Wayne Farms, LLC

Media Contact:
Keri McGrath Happe
+1 317-989-7011

General Inquiries

Elanco Animal Health
2500 Innovation Way
Greenfield, IN 46140 USA



Media Contacts

Contact us.

Our Global Offices

Follow Elanco

About Elanco

Elanco (NYSE: ELAN) is a global animal health company that develops products and knowledge services to prevent and treat disease in food animals and pets in more than 90 countries. With a 64-year heritage, we rigorously innovate to improve the health of animals and benefit our customers, while fostering an inclusive, cause-driven culture for more than 5,800 employees. At Elanco, we’re driven by our vision of food and companionship enriching life – all to advance the health of animals, people and the planet. Learn more at